Credo director sells 1,875 shares under 10b5-1 plan

Credo Technology Group Holding Ltd director share sale under 10b5-1 plan Director Pantas Sutardja reported selling 1,875 Ordinary Shares of Credo Technology Group Holding Ltd on January 30, 2026 at $128.67 per share.

Rhea-AI Filing Summary

Credo Technology Group Holding Ltd director share sale under 10b5-1 plan

Director Pantas Sutardja reported selling 1,875 Ordinary Shares of Credo Technology Group Holding Ltd on January 30, 2026 at $128.67 per share. After this trade, he beneficially owned 5,892,034 Ordinary Shares, held directly.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025, which allows systematic transactions set up in advance.

Insider Trade Summary

Net Seller: 1,875 shares

Net Sell 1 txn

Insider Sutardja, Pantas

Role Director

Sold 1,875 shs ($241K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,875	$128.67	$241K

Holdings After Transaction: Ordinary Shares — 5,892,034 shares (Direct)

Footnotes (1)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 26, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Credo Technology (CRDO) director Pantas Sutardja report in this Form 4?

Pantas Sutardja reported selling 1,875 Ordinary Shares of Credo Technology at $128.67 per share. The transaction occurred on January 30, 2026, and was reported as a direct ownership sale, leaving him with 5,892,034 Ordinary Shares beneficially owned.

How many Credo Technology (CRDO) shares does Pantas Sutardja still own after the sale?

After the reported sale, Pantas Sutardja beneficially owns 5,892,034 Ordinary Shares of Credo Technology. These shares are reported as directly held, reflecting his remaining stake following the 1,875-share disposition on January 30, 2026.

At what price were the Credo Technology (CRDO) shares sold in this Form 4?

The reported 1,875 Ordinary Shares were sold at a price of $128.67 per share. This sale price applies to the single transaction disclosed for January 30, 2026, under the non-derivative securities table in the Form 4 filing.

Was the Credo Technology (CRDO) Form 4 sale part of a Rule 10b5-1 trading plan?

Yes, the sale was executed under a Rule 10b5-1 trading plan. The footnote explains that the transactions were effected pursuant to a trading plan adopted by the reporting person on June 26, 2025, allowing pre-arranged, systematic share sales.

What is the role of the reporting person in Credo Technology (CRDO)?

The reporting person, Pantas Sutardja, is a director of Credo Technology Group Holding Ltd. The Form 4 identifies his relationship to the issuer as a director, with the director box checked and no officer or 10% owner status indicated.

Does this Credo Technology (CRDO) Form 4 include any derivative securities transactions?

No derivative securities transactions are reported in this Form 4. The derivative securities table is present but contains no entries, indicating that only non-derivative Ordinary Shares were involved in the disclosed transaction on January 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:21 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sutardja, Pantas

(Last) (First) (Middle)

110 RIO ROBLES

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Credo Technology Group Holding Ltd [ CRDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/30/2026		S(1)		1,875	D	$128.67	5,892,034	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 26, 2025.

Remarks:

	/s/ James Laufman, attorney-in-fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.